{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T22:52:14Z","timestamp":1768863134877,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,19]]},"DOI":"10.7759\/cureus.101823","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T09:39:30Z","timestamp":1768815570000},"source":"Crossref","is-referenced-by-count":0,"title":["Postoperative Management After Risk-Reducing Salpingo-Oophorectomy for Hereditary Breast and Ovarian Cancer Syndrome: A Narrative Review on Balancing Oncologic Benefit and Quality of Life"],"prefix":"10.7759","author":[{"given":"Hiroaki","family":"Ishida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou A","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, et al.. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003, 72:1117-30. 10.1086\/375033","journal-title":"Am J Hum Genet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj465","article-title":"Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada","volume":"98","author":"Risch HA","year":"2006","unstructured":"Risch HA, McLaughlin JR, Cole DE, et al.. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst. 2006, 98:1694-706. 10.1093\/jnci\/djj465","journal-title":"J Natl Cancer Inst"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group","volume":"30","author":"Alsop K","year":"2012","unstructured":"Alsop K, Fereday S, Meldrum C, et al.. BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol. 2012, 30:2654-63. 10.1200\/JCO.2011.39.8545","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek SM","year":"2010","unstructured":"Domchek SM, Friebel TM, Singer CF, et al.. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010, 304:967-75. 10.1001\/jama.2010.1237","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck TR","year":"2009","unstructured":"Rebbeck TR, Kauff ND, Domchek SM. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst. 2009, 101:80-7. 10.1093\/jnci\/djn442","journal-title":"J Natl Cancer Inst"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-014-0150-5","article-title":"Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers","volume":"14","author":"Marchetti C","year":"2014","unstructured":"Marchetti C, De Felice F, Palaia I, et al.. Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers. BMC Womens Health. 2014, 14:150. 10.1186\/s12905-014-0150-5","journal-title":"BMC Womens Health"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-28304-w","article-title":"Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in Japan","volume":"13","author":"Nomura H","year":"2023","unstructured":"Nomura H, Abe A, Fusegi A, et al.. Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in Japan. Sci Rep. 2023, 13:1018. 10.1038\/s41598-023-28304-w","journal-title":"Sci Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.0017","article-title":"NCCN guidelines insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020","volume":"18","author":"Daly MB","year":"2020","unstructured":"Daly MB, Pilarski R, Yurgelun MB, et al.. NCCN guidelines insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020. J Natl Compr Canc Netw. 2020, 18:380-91. 10.6004\/jnccn.2020.0017","journal-title":"J Natl Compr Canc Netw"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02016","article-title":"Risk of peritoneal carcinomatosis after risk-reducing salpingo-oophorectomy: a systematic review and individual patient data meta-analysis","volume":"40","author":"Steenbeek MP","year":"2022","unstructured":"Steenbeek MP, van Bommel MH, Bulten J, et al.. Risk of peritoneal carcinomatosis after risk-reducing salpingo-oophorectomy: a systematic review and individual patient data meta-analysis. J Clin Oncol. 2022, 40:1879-91. 10.1200\/JCO.21.02016","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012464.pub2","article-title":"Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations","volume":"8","author":"Eleje GU","year":"2018","unstructured":"Eleje GU, Eke AC, Ezebialu IU, Ikechebelu JI, Ugwu EO, Okonkwo OO. Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations. Cochrane Database Syst Rev. 2018, 8:CD012464. 10.1002\/14651858.CD012464.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2018.09.011","article-title":"Risk reduction and survival benefit of risk-reducing salpingo-oophorectomy in hereditary breast cancer: meta-analysis and systematic review","volume":"19","author":"Xiao YL","year":"2019","unstructured":"Xiao YL, Wang K, Liu Q, Li J, Zhang X, Li HY. Risk reduction and survival benefit of risk-reducing salpingo-oophorectomy in hereditary breast cancer: meta-analysis and systematic review. Clin Breast Cancer. 2019, 19:e48-65. 10.1016\/j.clbc.2018.09.011","journal-title":"Clin Breast Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(06)70869-5","article-title":"Survival patterns after oophorectomy in premenopausal women: a population-based cohort study","volume":"7","author":"Rocca WA","year":"2006","unstructured":"Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton LJ 3rd. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol. 2006, 7:821-8. 10.1016\/S1470-2045(06)70869-5","journal-title":"Lancet Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2022.33.e51","article-title":"Bone health after RRBSO among BRCA1\/2 mutation carriers: a population-based study","volume":"33","author":"do Valle HA","year":"2022","unstructured":"do Valle HA, Kaur P, Kwon JS, Cheifetz R, Dawson L, Hanley GE. Bone health after RRBSO among BRCA1\/2 mutation carriers: a population-based study. J Gynecol Oncol. 2022, 33:e51. 10.3802\/jgo.2022.33.e51","journal-title":"J Gynecol Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2021.07.029","article-title":"What happens after menopause? (WHAM): a prospective controlled study of vasomotor symptoms and menopause-related quality of life 12\u202fmonths after premenopausal risk-reducing salpingo-oophorectomy","volume":"163","author":"Hickey M","year":"2021","unstructured":"Hickey M, Moss KM, Krejany EO, et al.. What happens after menopause? (WHAM): a prospective controlled study of vasomotor symptoms and menopause-related quality of life 12\u202fmonths after premenopausal risk-reducing salpingo-oophorectomy. Gynecol Oncol. 2021, 163:148-54. 10.1016\/j.ygyno.2021.07.029","journal-title":"Gynecol Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17511","article-title":"Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations","volume":"130","author":"Nebgen DR","year":"2023","unstructured":"Nebgen DR, Domchek SM, Kotsopoulos J, et al.. Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations. BJOG. 2023, 130:1437-50. 10.1111\/1471-0528.17511","journal-title":"BJOG"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-010-1779-4","article-title":"Effects of three Kampo formulae: Tokishakuyakusan (TJ-23), Kamishoyosan (TJ-24), and Keishibukuryogan (TJ-25) on Japanese peri- and postmenopausal women with sleep disturbances","volume":"284","author":"Terauchi M","year":"2011","unstructured":"Terauchi M, Hiramitsu S, Akiyoshi M, et al.. Effects of three Kampo formulae: Tokishakuyakusan (TJ-23), Kamishoyosan (TJ-24), and Keishibukuryogan (TJ-25) on Japanese peri- and postmenopausal women with sleep disturbances. Arch Gynecol Obstet. 2011, 284:913-21. 10.1007\/s00404-010-1779-4","journal-title":"Arch Gynecol Obstet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e3182410159","article-title":"Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Taku K","year":"2012","unstructured":"Taku K, Melby MK, Kronenberg F, Kurzer MS, Messina M. Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials. Menopause. 2012, 19:776-90. 10.1097\/gme.0b013e3182410159","journal-title":"Menopause"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan MJ","year":"2007","unstructured":"Callahan MJ, Crum CP, Medeiros F, et al.. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol. 2007, 25:3985-90. 10.1200\/JCO.2007.12.2622","journal-title":"J Clin Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-021-03244-w","article-title":"Recommendations for diagnosing STIC: a systematic review and meta-analysis","volume":"480","author":"Bogaerts JM","year":"2022","unstructured":"Bogaerts JM, Steenbeek MP, van Bommel MH, Bulten J, van der Laak JA, de Hullu JA, Simons M. Recommendations for diagnosing STIC: a systematic review and meta-analysis. Virchows Arch. 2022, 480:725-37. 10.1007\/s00428-021-03244-w","journal-title":"Virchows Arch"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2020.31.e45","article-title":"A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG): disparity between serous carcinoma and clear cell carcinoma","volume":"31","author":"Yamagami W","year":"2020","unstructured":"Yamagami W, Nagase S, Takahashi F, et al.. A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG): disparity between serous carcinoma and clear cell carcinoma. J Gynecol Oncol. 2020, 31:e45. 10.3802\/jgo.2020.31.e45","journal-title":"J Gynecol Oncol"},{"key":"ref21","unstructured":"Ovarian cancer statistics. (2024). Accessed. n.d: https:\/\/ocrahope.org\/for-patients\/gynecologic-cancers\/ovarian-cancer\/ovarian-cancer-statistics\/."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.11.015","article-title":"ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease","volume":"35","author":"Ledermann JA","year":"2024","unstructured":"Ledermann JA, Matias-Guiu X, Amant F, et al.. ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease. Ann Oncol. 2024, 35:248-66. 10.1016\/j.annonc.2023.11.015","journal-title":"Ann Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.10.004","article-title":"Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline","volume":"34","author":"Sessa C","year":"2023","unstructured":"Sessa C, Balma\u00f1a J, Bober SL, et al.. Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline. Ann Oncol. 2023, 34:33-47. 10.1016\/j.annonc.2022.10.004","journal-title":"Ann Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.78732","article-title":"A retrospective study of 10 cases of laparoscopic and laparotomic risk-reducing salpingo-oophorectomy performed on patients with BRCA-positive breast cancer","volume":"17","author":"Ishida H","year":"2025","unstructured":"Ishida H, Manrai M, Egashira H, Arakawa K, Takashima A. A retrospective study of 10 cases of laparoscopic and laparotomic risk-reducing salpingo-oophorectomy performed on patients with BRCA-positive breast cancer. Cureus. 2025, 17:e78732. 10.7759\/cureus.78732","journal-title":"Cureus"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.1590","article-title":"Association of salpingectomy with delayed oophorectomy versus salpingo-oophorectomy with quality of life in BRCA1\/2 pathogenic variant carriers: a nonrandomized controlled trial","volume":"7","author":"Steenbeek MP","year":"2021","unstructured":"Steenbeek MP, Harmsen MG, Hoogerbrugge N, et al.. Association of salpingectomy with delayed oophorectomy versus salpingo-oophorectomy with quality of life in BRCA1\/2 pathogenic variant carriers: a nonrandomized controlled trial. JAMA Oncol. 2021, 7:1203-12. 10.1001\/jamaoncol.2021.1590","journal-title":"JAMA Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/457324-postoperative-management-after-risk-reducing-salpingo-oophorectomy-for-hereditary-breast-and-ovarian-cancer-syndrome-a-narrative-review-on-balancing-oncologic-benefit-and-quality-of-life","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T09:39:35Z","timestamp":1768815575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/457324-postoperative-management-after-risk-reducing-salpingo-oophorectomy-for-hereditary-breast-and-ovarian-cancer-syndrome-a-narrative-review-on-balancing-oncologic-benefit-and-quality-of-life"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.101823","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,19]]}}}